A study led by Pohang University of Science and Technology (POSTECH) and the Institute for Bioengineering of Catalonia (IBEC) in South Korea details the creation of urea-powered nanomotors that enhance immunotherapy for bladder cancer. The nanomotors open up new possibilities in oncology by more effectively activating the immune system and surpassing the effectiveness of currently used treatments. The study was published in the journal Nature Communications.
Immunotherapy using BCG (Bacillus Calmette-Guérin), a weakened bacterium injected into the bladder to trigger an immune response against tumor cells, is currently the standard treatment for non-invasive bladder cancer. Significant drawbacks of this treatment include the requirement for repeated doses, serious adverse effects, and decreased effectiveness in some patients. The novel nanomotor-based treatment provides a more potent substitute, which considerably slows the growth of tumors in preclinical mouse models and more effectively activates the immune system.
Urease is an enzyme these self-propelled nanoparticles use to react with urine urea. Their mobility allows them to be dispersed more effectively throughout the bladder, precisely reaching tumor cells and extending the duration of the medication’s presence in the impacted tissue.
The nanomotors’ surface contains a STING agonist, a crucial molecule in immune system activation.
We have shown that our approach is more effective than conventional BCG treatment in mice, which is a breakthrough in immunotherapy for this type of cancer.
Samuel Sánchez, Study Co-Leader and ICREA Research Professor, Institute for Bioengineering of Catalonia (IBEC)
The researchers paired the nanomotors with a PD-1 inhibitor, a medication that prevents tumor cells from using an escape mechanism, to further strengthen the immune response.
“The combination of our nanomotors with the anti-PD-1 treatment showed a remarkable synergy that could lead to more effective combination therapies with fewer side effects,” added Sánchez.
The study marks a significant advancement in the hunt for novel treatment approaches for bladder cancer, a condition that necessitates intensive and protracted care due to its high recurrence rate.
This study’s participants included PHI BIOMED Co., the Korea Advanced Institute of Science and Technology (KAIST), CIC biomaGUNE of the Basque Country, Seoul National University, and Seoul National University Hospital.
Journal Reference:
Choi, H., et al. (2025) Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy. Nature Communications. doi.org/10.1038/s41467-024-54293-z
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
